Search research articles
Contact Us
Filters
Showing results (1-10 of 131) with videos related to
Page
of 14
Sort By:
The Diabetes Educator
|
August 2, 2008
Barriers to medication adherence in poorly controlled diabetes mellitus
Peggy Soule Odegard, Shelly L Gray
BMJ (Clinical Research Ed.)
|
April 27, 2018
Anticholinergic drugs and dementia in older adults
Shelly L Gray, Joseph T Hanlon
The Annals of Pharmacotherapy
|
March 15, 2012
Cholinesterase inhibitor adjunctive therapy for cognitive impairment and depressive symptoms in older adults with depression
Cara L McDermott, Shelly L Gray
BMJ (Clinical Research Ed.)
|
August 11, 2019
Post-finasteride syndrome
Shelly L Gray, Todd P Semla
Therapeutic Advances in Drug Safety
|
October 4, 2016
Anticholinergic medication use and dementia: latest evidence and clinical implications
Shelly L Gray, Joseph T Hanlon
Journal of the American Geriatrics Society
|
May 21, 2022
Deprescribing trials: A focus on adverse drug withdrawal events
Joseph T Hanlon, Shelly L Gray
The Annals of Pharmacotherapy
|
May 7, 2009
Implications for pharmacy from the Institute of Medicine's report on Health Care Workforce and an Aging America
Shelly L Gray, David Elliott, Todd Semla
JAMA Internal Medicine
|
September 9, 2015
Anticholinergic Use With Incident Dementia--Reply
Shelly L Gray, Melissa Anderson, Rebecca Hubbard
The Annals of Pharmacotherapy
|
May 28, 2009
Assessment of older adults' knowledge of and preferences for medication management tools and support systems
Susan L Lakey, Shelly L Gray, Soo Borson
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 19, 2016
Nitrate Medications, Fractures, and Change in Bone Mineral Density in Postmenopausal Women: Results from the Women's Health Initiative
Negar Golchin, Chancellor Hohensee, Andrea LaCroix, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 131) with videos related to
Sort By:
Page
of 14
The Diabetes Educator
|
August 2, 2008
Barriers to medication adherence in poorly controlled diabetes mellitus
Peggy Soule Odegard, Shelly L Gray
BMJ (Clinical Research Ed.)
|
April 27, 2018
Anticholinergic drugs and dementia in older adults
Shelly L Gray, Joseph T Hanlon
The Annals of Pharmacotherapy
|
March 15, 2012
Cholinesterase inhibitor adjunctive therapy for cognitive impairment and depressive symptoms in older adults with depression
Cara L McDermott, Shelly L Gray
BMJ (Clinical Research Ed.)
|
August 11, 2019
Post-finasteride syndrome
Shelly L Gray, Todd P Semla
Therapeutic Advances in Drug Safety
|
October 4, 2016
Anticholinergic medication use and dementia: latest evidence and clinical implications
Shelly L Gray, Joseph T Hanlon
Journal of the American Geriatrics Society
|
May 21, 2022
Deprescribing trials: A focus on adverse drug withdrawal events
Joseph T Hanlon, Shelly L Gray
The Annals of Pharmacotherapy
|
May 7, 2009
Implications for pharmacy from the Institute of Medicine's report on Health Care Workforce and an Aging America
Shelly L Gray, David Elliott, Todd Semla
JAMA Internal Medicine
|
September 9, 2015
Anticholinergic Use With Incident Dementia--Reply
Shelly L Gray, Melissa Anderson, Rebecca Hubbard
The Annals of Pharmacotherapy
|
May 28, 2009
Assessment of older adults' knowledge of and preferences for medication management tools and support systems
Susan L Lakey, Shelly L Gray, Soo Borson
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 19, 2016
Nitrate Medications, Fractures, and Change in Bone Mineral Density in Postmenopausal Women: Results from the Women's Health Initiative
Negar Golchin, Chancellor Hohensee, Andrea LaCroix, et al.
Page
of 14